Thomas P Conrads
Overview
Explore the profile of Thomas P Conrads including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
257
Citations
7700
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kimble D, Litzi T, Snyder G, Olowu V, TaQee S, Conrads K, et al.
Biol Methods Protoc
. 2024 Oct;
9(1):bpae066.
PMID: 39421215
A central theme in cancer research is to increase our understanding of the cancer tissue microenvironment, which is comprised of a complex and spatially heterogeneous ecosystem of malignant and non-malignant...
2.
Johnston L, Randall J, Chouraichi S, Luu M, Hunt A, Mauro L, et al.
NPJ Precis Oncol
. 2024 Sep;
8(1):203.
PMID: 39277699
Recent trials have shown the efficacy of trastuzumab deruxtecan (T-DXd) in HER2-negative patients, but there is not yet a way to identify which patients will best respond, especially with the...
3.
Panigrahi A, Hunt A, Assis D, Willetts M, Kallakury B, Davidson B, et al.
bioRxiv
. 2024 Aug;
PMID: 39149249
We employed laser microdissection to selectively harvest tumor cells and stroma from the microenvironment of formalin-fixed, paraffin-embedded head and neck squamous cell carcinoma (HNSCC) tissues. The captured HNSCC tissue fractions...
4.
Bateman N, Abulez T, Tarney C, Bariani M, Driscoll J, Soltis A, et al.
Am J Obstet Gynecol
. 2024 May;
231(3):321.e1-321.e11.
PMID: 38723985
Background: Black women are at an increased risk of developing uterine leiomyomas and experiencing worse disease prognosis than White women. Epidemiologic and molecular factors have been identified as underlying these...
5.
Bateman N, Abulez T, Soltis A, McPherson A, Choi S, Garsed D, et al.
NPJ Precis Oncol
. 2024 May;
8(1):97.
PMID: 38710993
No abstract available.
6.
Kopelman Z, Tian C, Tumas J, Phippen N, Tarney C, Hope E, et al.
Gynecol Oncol
. 2024 Apr;
183:103-114.
PMID: 38593674
Objective: Investigate racial disparities in outcomes and molecular features in Black and White patients with endometrioid endometrial carcinoma (EEC). Methods: Black and White patients diagnosed with EEC who underwent hysterectomy...
7.
Randall J, Hunt A, Nutcharoen A, Johnston L, Chouraichi S, Wang H, et al.
Clin Proteomics
. 2024 Mar;
21(1):24.
PMID: 38509475
Metastatic pancreatic adenocarcinoma (PDAC) is the third leading cause of cancer-related death in the United States, with a 5-year survival rate of only 11%, necessitating identification of novel treatment paradigms....
8.
Bateman N, Abulez T, Soltis A, McPherson A, Choi S, Garsed D, et al.
NPJ Precis Oncol
. 2024 Mar;
8(1):68.
PMID: 38480868
We performed a deep proteogenomic analysis of bulk tumor and laser microdissection enriched tumor cell populations from high-grade serous ovarian cancer (HGSOC) tissue specimens spanning a broad spectrum of purity....
9.
Sitler C, Tian C, Hamilton C, Richardson M, Chan J, Kapp D, et al.
Cancers (Basel)
. 2024 Mar;
16(5).
PMID: 38473428
Purpose: To investigate IMT use and survival in real-world stage IVB cervical cancer patients outside randomized clinical trials. Methods: Patients diagnosed with stage IVB cervical cancer during 2013-2019 in the...
10.
Teng P, Schaaf J, Abulez T, Hood B, Wilson K, Litzi T, et al.
iScience
. 2024 Mar;
27(3):109198.
PMID: 38439970
Numerous multi-omic investigations of cancer tissue have documented varying and poor pairwise transcript:protein quantitative correlations, and most deconvolution tools aiming to predict cell type proportions (cell admixture) have been developed...